A Pilot Study of mDOT for Immunosuppressant Adherence in Adolescent Kidney

Status Completed

Clinical Trial Summary

The investigators are interested in whether or not the use of a mobile health (mHealth) application increases the rate of immunosuppression medication adherence among adolescent kidney transplant recipients. The investigators aim to test this by recruiting adolescent (ages 14-21) kidney transplant recipients to use an mHealth application to record themselves taking their immunosuppression medications, and tracking medication adherence over time. The study population will be approximately 50 adolescent kidney transplant recipients at the Johns Hopkins Hospital.

Clinical Trial Description

In kidney transplant recipients, non-adherence to immunosuppressant medications post-transplant has been associated with a range of negative implications, including increased healthcare utilization, rejection of the graft, kidney loss, and death. Specifically, adolescents and young adults are the most at risk populations for experiencing death-censored graft loss and medication non-adherence. Previous studies have reported rates of non-adherence in this population ranging from 50-70%, and even minor deviations in immunosuppressant medication adherence have been shown to have negative effects. The use of mobile health (mHealth) technology could prove useful in aiding transplant recipients to stay adherent to their medical regimen. We will use a mobile health platform that enables users to track dose-by-dose medication adherence through asynchronous, video directly observed therapy (DOT). This helps patients take their medication as prescribed and gives providers the assurance that their patients are supported and successful in treatment. DOT is the practice of watching a patient take every dose of medicine in-person, and has typically only been done in extreme cases because it can be both costly and burdensome: DOT is the standard of care for Tuberculosis treatment and has proven high-adherence rates. Through mHealth technology, DOT can be used more broadly and without added burden; emocha's technology allows this through enabling patients to use their mobile application to view their regimen, record themselves taking every dose of their medication, report side effects or symptoms, visualize their treatment progress, access educational content, and track appointments. This information is encrypted and transmitted to a HIPAA-secure web portal for providers to review. The aim of this study is to perform a pilot trial examining the rates of medication adherence in adolescent kidney transplant recipients who use a novel mHealth system, and to understand the acceptability/satisfaction with using this technology. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03504137
Study type	Interventional
Source	Johns Hopkins University
Contact
Status	Completed
Phase	N/A
Start date	March 4, 2020
Completion date	August 28, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04709640` - Pilot Study to Improve Medication Management in Older Adults	N/A
Completed	`NCT03257579` - Myocardial Infarction Prescription Duration Adherence Study	N/A
Completed	`NCT05376397` - Testing THRIVE 365 for Black Sexual Minority Men (On The Daily)	N/A
Withdrawn	`NCT03427008` - A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Kidney Transplant Recipients	N/A
Completed	`NCT03805451` - Life Steps for PrEP for Youth	N/A
Withdrawn	`NCT03292393` - Social Norms and Antihypertensive Medication Adherence	N/A
Not yet recruiting	`NCT02876848` - A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study)	N/A
Completed	`NCT02914730` - Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
Completed	`NCT02823795` - The Supporting Patient Activation in Transition to Home Intervention	N/A
Completed	`NCT02066935` - Non-adherence to Immunosuppressives in Kidney Transplantation in Brazil Multicenter Study
Completed	`NCT02797262` - Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System	N/A
Completed	`NCT01934608` - The Effect of Synching Prescription Refills on Adherence	N/A
Completed	`NCT01770314` - Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication.	Phase 2
Completed	`NCT01741311` - Secondary HIV Prevention and Adherence Among HIV-infected Drug Users	N/A
Recruiting	`NCT01105104` - An Enhanced Medication Monitoring Program	Phase 1
Completed	`NCT01859273` - Adherence Enhancement for Renal Transplant Patients	N/A
Withdrawn	`NCT01430702` - Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults	N/A
Completed	`NCT01118208` - Blister Packaging Medication to Increase Treatment Adherence and Clinical Response	N/A
Completed	`NCT00848224` - Improving Adherence to Pharmacological Treatment	N/A
Completed	`NCT06034301` - Pill Bottle vs Reminder App	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Pilot Study of mDOT for Immunosuppressant Adherence in Adolescent Kidney Transplant Recipients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms